NDC Code(s) : 70518-0859-0, 70518-0859-1
Packager : REMEDYREPACK INC.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Bupropion HydrochlorideBupropion Hydrochloride TABLET, EXTENDED RELEASE | ||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
LABELER - REMEDYREPACK INC.(829572556) |
PRINCIPAL DISPLAY PANEL
DRUG: Bupropion Hydrochloride
GENERIC: Bupropion Hydrochloride
DOSAGE: TABLET, EXTENDED RELEASE
ADMINSTRATION: ORAL
NDC: 70518-0859-0
NDC: 70518-0859-1
COLOR: white
SHAPE: ROUND
SCORE: No score
SIZE: 7 mm
IMPRINT: L015
PACKAGING: 30 in 1 BLISTER PACK
PACKAGING: 30 in 1 BOTTLE PLASTIC
ACTIVE INGREDIENT(S):
- BUPROPION HYDROCHLORIDE 150mg in 1
INACTIVE INGREDIENT(S):
- AMMONIA
- CYSTEINE HYDROCHLORIDE
- DIBUTYL SEBACATE
- ETHYLCELLULOSES
- FERROSOFERRIC OXIDE
- GLYCERYL BEHENATE/EICOSADIOATE
- HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
- METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
- POLYVINYL ALCOHOL, UNSPECIFIED
- POVIDONE
- PROPYLENE GLYCOL
- SHELLAC
- SILICA DIMETHYL SILYLATE
- SILICON DIOXIDE
- TRIETHYL CITRATE